Mostrando 10 resultados de: 13
Publisher
The Lancet Infectious Diseases(4)
Nature Communications(2)
Allergologia et Immunopathologia(1)
BMJ Open(1)
ERJ Open Research(1)
Área temáticas
Medicina y salud(8)
Enfermedades(5)
Medicina forense; incidencia de enfermedades(4)
Farmacología y terapéutica(3)
Problemas sociales y servicios a grupos(2)
Objetivos de Desarrollo Sostenible
ODS 3: Salud y bienestar(13)
ODS 17: Alianzas para lograr los objetivos(11)
ODS 4: Educación de calidad(1)
ODS 5: Igualdad de género(1)
Origen
scopus(13)
Asthma inflammatory phenotypes on four continents: most asthma is non-eosinophilic
ArticleAbstract: BACKGROUND: Most studies assessing pathophysiological heterogeneity in asthma have been conducted inPalabras claves:adolescents, Asthma, CHILDREN, HIC, inflammatory phenotypes, LMIC, sputum inductionAutores:Ali H., Brooks C., Cruz A.A., Douwes J., Figueiredo C.A.V., Henderson J., Martha E. Chico, Mauricio L. Barreto, Mpairwe H., Nambuya I., Oviedo A.Y., Pearce N., Pembrey L., Philip John Cooper, Ring S., Robertson S., Rutter C.E., Tumwesige P., van Veldhoven K.Fuentes:scopusDuration of protection of CoronaVac plus heterologous BNT162b2 booster in the Omicron period in Brazil
ArticleAbstract: To date, no information has been published on the effectiveness of inactivated whole-virus COVID-19Palabras claves:Autores:Barral-Netto M., Boaventura V.S., Cerqueira-Silva T., de Araujo Oliveira V., Júnior J.B.S., Mauricio L. Barreto, Paixão E.S., Pearce N., Penna G.O., Werneck G.L.Fuentes:scopusEffectiveness of BNT162b2 booster after CoronaVac primary regimen in pregnant people during omicron period in Brazil
OtherAbstract:Palabras claves:Autores:Alves F.J.O., Barral-Netto M., Boaventura V.S., Cerqueira-Silva T., de Araujo Oliveira V., Florentino P.T.V., Júnior J.B.S., Mauricio L. Barreto, Paixão E.S., Pearce N., Penna G.O., Rodrigues L.C., Werneck G.L.Fuentes:scopusEffectiveness of CoronaVac, ChAdOx1 nCoV-19, BNT162b2, and Ad26.COV2.S among individuals with previous SARS-CoV-2 infection in Brazil: a test-negative, case-control study
ArticleAbstract: Background: COVID-19 vaccines have proven highly effective among individuals without a previous SARSPalabras claves:Autores:Andrews J.R., Barral-Netto M., Boaventura V.S., Cerqueira-Silva T., Croda J., Cummings D.A.T., de Araujo Oliveira V., Dean N.E., Dorion M., Hitchings M.D.T., Júnior J.B.S., Ko A.I., Lind M.L., Machado T.M., Mauricio L. Barreto, Paixão E.S., Pearce N., Penna G.O., Ranzani O.T., Werneck G.L.Fuentes:scopusEffectiveness of mRNA boosters after homologous primary series with BNT162b2 or ChAdOx1 against symptomatic infection and severe COVID-19 in Brazil and Scotland: A test-negative design case–control study
ArticleAbstract: Background AU Brazil: and Scotland have used mRNA boosters in their respective : populations since SPalabras claves:Autores:Barral-Netto M., Boaventura V.S., Cerqueira-Silva T., de Araujo Oliveira V., Júnior J.B.S., Katikireddi S.V., Mauricio L. Barreto, Paixão E.S., Pearce N., Penna G.O., Robertson C., Rudan I., Sanchez M., Shah S.A., Sheikh A., Werneck G.L.Fuentes:scopusGlobal Asthma Network survey suggests more national asthma strategies could reduce burden of asthma
ArticleAbstract: Background Several countries or regions within countries have an effective national asthma strategyPalabras claves:Asthma, burden, global, management, National, network, STRATEGIESAutores:Addo-Yobo E.O., Aguirre de Abruzzese J., Akpinar-Elci M., Annesi-Maesano I., Asher I., Awasthi S., Baghdasaryan A., Banac S., Barba S., Benhabylès B., Berihu A., Billo N.E., Birba E., Bissell K., Boukari R., Brandão H.V., Burgess S., Calvo Gil M.A., Camargos P.A.M., Castracane F.A., Charpin D., Chen Y.Z., Cheraghi M., Chiang C.Y., Clement N.F., de Britto M., Domuz S., El Falaki M., El Sony A., Ellwood E., Ellwood P., Figueroa Colorado M., Fischer G.B., Garcia E., Gninafon M., Gómez M., Gotua M., Gratziou C., Haahtela T., Haidinger G., Ilangho R., Kabengele Obel B., Kan X., Karimi M., Kartasasmita C.B., Kuschnir F.C., Lai C.K.W., Lal V.A., Lin Y., Lochte L., Maitra A., Makela M.J., Mallol J., Manning P., Marcos L.G., Marks G.B., Masjedi M.R., Mattes J., Mbatchou Ngahane B.H., Menezes A.M., Mokhtar A., Mukherjee M., Mustakov T.B., Niederbacher J., Novák Z., Ordoñez G.A., Pai U.A., Pearce N., Pefura Yone E.W., Pherwani A.V., Philip John Cooper, Porto Neto A.C., Priftanji A., Raherison C., Reddy B.K., Rennie D.C., Riedler J., Rosário N., Sabir M., Salmun N., Selroos O., Sharma S.K., Shohat T., Shpakou A., Singh M., Singh V., Solé D., Soto-Quiros M.E., Standring P., Strachan D., Sukumaran T.U., Tai A., To T., Tsanakas J., Varkki S., Von Mutius E., Wandalsen N.F., Weihe P., Weyler J., Yiallouros P.Fuentes:scopusEpidemiology, molecular, and genetic methodologies to evaluate causes of CKDu around the world: report of the Working Group from the ISN International Consortium of Collaborators on CKDu
OtherAbstract:Palabras claves:Chronic kidney disease, epidemiology, Ethics, Global Health, interstitial nephritis, Molecular diagnostic techniquesAutores:Abbot K., Abeysekara T., Aguilar-Gonzalez A., Amann K., Anand S., Ashuntantang G., Bhalla V., Brooks D.R., Caplin B., Chavarria D., Christoph D., De Broe M., De Silva P.M.C.S., Dominguez J., Eckardt K.U., Fader D., Finkelstein F., Fire A., Fischer R., Friedman D.J., Ganguli A., Garcia Trabinho R.A., Glaser J., Haider L.(., Harris D., Herath C., Herrera R., Hoy W., Hradsky A., Jakobsson K., Jayasinghe S., Jaysummana C., Jha V., Johnson R., Kambham N., Karanasema N., Kaze F., Kimmel P., Koritzinsky E., Langham R., Le Bellego L., Levin A., Levin N., Lyuckx V., Madero M., Malik C., Martin E., Marvin Antonio González-Quiroz, Moist L., Moxey-Mims M., Nanayakkara N., Narva A., Nerbass F., O'Donoghue D., Orantes C., Parada X., Pearce N., Ratnayake C., Rotter R.C., Roy-Chaudhury P., Ruggiero A., Sanchez-Lozada L.G., Saran R., Schensul S.L., Segantini L., Seksek I., Sheikh-Hamad D., Star R., Strani L., Vlahos P., Wegman D.H., Weiss I., Wijewickrama E., Wijkström J., Wise P.H., Wright E., Yang C.W., Yeates K.E.Fuentes:scopusUnderstanding asthma phenotypes: The world asthma phenotypes (WASP) international collaboration
ArticleAbstract: The World Asthma Phenotypes (WASP) study started in 2016 and has been conducted in five centres, inPalabras claves:Autores:Ardura-Garcia C., Brooks C., Cruz A.A., Douwes J., Elliott A.M., Figueiredo C.A.V., Henderson J., Langan S.M., Martha E. Chico, Mauricio L. Barreto, Mpairwe H., Nassanga B., Pearce N., Pembrey L., Philip John Cooper, Ring S., Rodrigues L.C.Fuentes:scopusVaccination plus previous infection: protection during the omicron wave in Brazil
OtherAbstract:Palabras claves:Autores:Barral-Netto M., Boaventura V.S., Cerqueira-Silva T., de Araujo Oliveira V., Florentino P.T.V., Mauricio L. Barreto, Paixão E.S., Pearce N., Penna G.O., Werneck G.L.Fuentes:scopusVaccine effectiveness of CoronaVac against COVID-19 among children in Brazil during the Omicron period
ArticleAbstract: Although severe COVID-19 in children is rare, they may develop multisystem inflammatory syndrome, loPalabras claves:Autores:Alves F.J.O., Barral-Netto M., Boaventura V.S., Cerqueira-Silva T., Florentino P.T.V., Jantsch A.G., Júnior J.B.S., Mauricio L. Barreto, Oliveira V.D.A., Paixão E.S., Pearce N., Penna G.O., Rodrigues L.C., Werneck G.L.Fuentes:scopus